ClinicalTrials.gg
CompletedNCT03316755RPPDUpdated Oct 20, 2017

Risk Perception of Periodontal Disease

An interventional study of Exposure in Periodontal Diseases, sponsored by University of Benin. Completed at 1 site in Nigeria. Open to participants aged 16 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-20.

Sponsored by University of Benin · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Mar 2017, registered Oct 2017).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
16 Years to 60 Years
Sex
All
01

Study summary

This study aimed at understanding the impact of educational pamphlet on Risk Perception of Periodontal Disease using A Randomised Clinical Trial model among patients in a Nigerian outpatient dental clinic

Read the detailed description

This study aimed at understanding the impact of educational pamphlet on Risk Perception of Periodontal Disease using A Randomised Clinical Trial model among patients in a Nigerian outpatient dental clinic. The outcome will help activate a success oriented periodontal disease prevention model

02

Conditions studied

  • Periodontal Diseases

Browse trials for

03

In context

Periodontal Diseases

867 studies on the registry are indexed under Periodontal Diseases; 189 are open to participants now.

This study's enrollment of 300 is above the median of 45 across 557 interventional studies indexed under Periodontal Diseases.

Browse Periodontal Diseases studies →

Lead sponsor

University of Benin is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • consenting dental patients

Exclusion criteria

Exclusion Criteria:

  • non consenting dental patients
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
300 participants (actual)

Study arms

  • No intervention
    without pamphlet

    a group not exposed to pamphlet

  • Experimental
    With pamphlets

    a group exposed to pamphlet

    Behavioral: Exposure

Interventions

  • BehavioralExposure

    Exposure to pamphlet

06

What researchers measure

Primary outcomes

  1. Risk perception

    Questionnaire

    Time frame: 1month

07

Study locations

1 site
  • UBenin
    Benin City, Edo State 300001, Nigeria
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2017 to primary completion in Oct 2017, 7 months.

Of 312 non-industry interventional studies with no phase under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 28. This study's 7 months is below that.

Counting every sponsor, half of 331 studies reached it within 13 months; a quarter within 8 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2017
First posted
Oct 20, 2017
StartActual
Mar 1, 2017
Primary completionActual
Oct 4, 2017
CompletionActual
Oct 7, 2017
Last update
Oct 20, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 20, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03316755
Lead sponsor
University of Benin
Responsible party
Clement Chinedu Azodo (Head of Department, University of Benin) — Principal investigator
First posted
Oct 20, 2017
Start date
Mar 1, 2017
Primary completion
Oct 4, 2017
Completion
Oct 7, 2017
Last update
Oct 20, 2017

Study contacts

Clement C Azodo
principal investigator · UBTH

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion